Table 7 Risk factors for positivity to CVBD agents

Positivity

  ≥ 1 year

0.011

1.94

1.15–3.29

 Medium size

0.003

1.54

1.16–2.07

 Large size

0.002

1.42

1.14–1.79

 Outdoors

< 0.0001

2.33

1.82–2.98

 Tick contact

< 0.0001

7.13

4.89–10.39

 TTI prevention

< 0.0001

2.58

1.66–4.03

 Clinical signs

< 0.0001

3.58

2.91–4.42

Positivity to A

 Outdoors

0.001

2.02

1.31–3.09

 Tick contact

< 0.0001

11.93

4.39–32.42

 Clinical signs

< 0.0001

2.63

1.88–3.67

Positivity to Bb

 Clinical signs

0.022

nd

nd

Positivity to Di

 Medium size

0.035

1.83

1.03–3.24

 Large size

0.004

2.04

1.24–3.36

 Outdoors

< 0.0001

4.12

1.98–8.59

 Tick contact

0.002

3.24

1.48–7.08

 Clinical signs

< 0.0001

2.52

1.61–3.95

Positivity to Ec

  ≥ 1 year

0.014

2.02

1.14–3.57

 Medium size

0.018

1.44

1.06–1.94

 Large size

0.009

1.37

1.08–1.74

 Outdoors

< 0.0001

2.21

1.69–2.87

 Tick contact

< 0.0001

7.23

4.74–11.04

 TTI prevention

< 0.0001

3.27

2.10–5.09

 Clinical signs

< 0.0001

3.58

2.88–4.45

Co-infections

 Large size

0.007

1.75

1.16–2.62

 Outdoors

< 0.0001

3.06

1.82–5.14

 Tick contact

< 0.0001

14.22

4.50–44.91

 TTI prevention

0.033

1.93

1.04–3.58

 Clinical signs

< 0.0001

4.08

2.79–5.96